Good afternoon :)
$
₹
Context Therapeutics Inc

Context Therapeutics Inc

CNTX

NASDAQ
$0.192.71% (+0.00)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $18.7M the stock is ranked 5488

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.46
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.48
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 10 analysts reports

Buy
9 analysts
Hold
1 analyst
Sell
0 analyst

Price Upside

+2104.84%

Earnings Growth

-21.05%

Rev. Growth

—

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
45.74
45.74
1Y Return
44.64%
44.64%
Buy Reco %
83.87
83.87
P/E Ratio
41.93
41.93
1Y Return
48.67%
48.67%
Buy Reco %
69.56
69.56
P/E Ratio
151.87
151.87
1Y Return
71.05%
71.05%
Buy Reco %
67.85
67.85
P/E Ratio
31.48
31.48
1Y Return
28.42%
28.42%
Buy Reco %
41.66
41.66
P/E Ratio
26.73
26.73
1Y Return
10.56%
10.56%
Buy Reco %
75.00
75.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

-9.6
-13
-8.6
-14.5
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue0000000000
Net Income-3.66-2.25-17.45-3.34-4.57-8.82-9.69-13.02-8.68-14.55
Net Profit Margin----------

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Context Therapeutics Inc -0.46-
Eli Lilly and Company45.7431.171.32
Johnson & Johnson41.937.852.99

Price Comparison

Price Comparison

Compare CNTX with any stock or ETF
Compare CNTX with any stock or ETF
Comparing from
CNTX
LLY
JNJ
Loading...

Frequently asked questions

  1. Context Therapeutics Inc (CNTX) share price today is $0.19 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $0.20 and a day low of $0.18.

  2. Context Therapeutics Inc stock trades on NASDAQ under the ticker symbol CNTX.

  3. Context Therapeutics Inc's market capitalization is $18.69M as of November 7, 2026 at 2:29 AM IST.

  4. Context Therapeutics Inc's price-to-earnings (P/E) ratio is N/A as of November 6, 2026.

  5. Context Therapeutics Inc's price-to-book (P/B) ratio is 0.46 as of November 6, 2026.

  6. Yes, You can buy Context Therapeutics Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Context Therapeutics Inc shares in three steps: 1. Search Context Therapeutics Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Context Therapeutics Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Context Therapeutics Inc (CNTX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 51.8134 shares at the current price of $0.19.

Loading...